cor2ed
engage checkpoint medical linkedin twitter
bg

How can we understand and define re-challenge in the treatment of mCRC?

How can we understand and define re-challenge in the treatment of mCRC?

Dr. Dominik Modest

Dr. Dominik Modest addresses the clinical question: how can we understand and define re-challenge in the treatment of mCRC?
Portrait of Dominik Modest
Dr. Dominik Modest

Medical Oncologist

Charité Universitaetsmedizin

Germany

preview next

time Expert View | open 5 min | 2019

download resources

I agree that this educational programme:

GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.

Other programmes of interest

preview next